NRC — Zebrafish Research Facility Grant Analysis ### 📋 Eligible Entities - Canadian corporations (private and public) - Academic institutions and research organizations - Biotechnology and pharmaceutical companies - Natural health products manufacturers and distributors - Contract Research Organizations (CROs) - Small and medium-sized enterprises (SMEs) in life sciences - Health therapeutics developers - Companies seeking third-party toxicological or pharmacological testing services Note: This is a fee-for-service facility, so users pay for testing rather than receiving direct grants --- ### 💰 Funding Details - Structure: Fee-for-service model (NOT a direct grant to users) - Cost Recovery: Services are charged on a per-project basis - Typical Service Fees: Variable depending on testing complexity and scope - Payment Terms: Negotiable based on client and project size - No Repayment Required: Service payments are standard operating expenses for clients - Matching Contributions: N/A (facility is NRC-funded infrastructure) - Budget Availability: Dependent on NRC annual allocation and facility capacity --- ### 🛠️ Approved Expenses Testing and evaluation services include: - Toxicological assessments for natural health products - Pharmacological activity evaluation for human health therapeutics - Zebrafish bioassay testing (primary model organism) - In vivo screening and safety profiling - Regulatory compliance testing (Health Canada, FDA alignment) - Drug candidate evaluation - Natural product efficacy and safety screening - Data analysis and reporting - Quality assurance and documentation --- ### ⚠️ Conditions & Milestones Key Requirements: - Project Scope Definition: Clear research objectives and testing parameters must be established upfront - Regulatory Alignment: Testing protocols must meet Health Canada and international standards - Timeline: Variable project duration (typically 4-12 weeks depending on complexity) - Data Ownership: Negotiated IP agreements determine confidentiality and publication rights -